In our hands, a nonsignificant trend toward significance of reduced circulating insulin and HOMA-IR index (p = 0.069 and 0.093, respectively) occurred in those HER2+ BC patients with any C allele of the rs11212617 SNV treated with metformin. Here, ERBB2 is linked to breast cancer.